Brainsway BWAY
NASDAQ BWAY
$11.51 -0.47 (-3.92%)
As of: Oct 22, 2026 · 11:48 AM EDT

Brainsway (BWAY) EBITDA Margin (2018 - 2026)

Updated

Brainsway's EBITDA Margin was 15.37% in the quarter ended Jun 30, 2026, up 9.37 percentage points from 6.00% a year earlier and up 1.39 percentage points from the prior quarter.

Analysis

Brainsway (BWAY) EBITDA Margin (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Brainsway's EBITDA Margin was 13.62% through Jun 30, 2026, up 7.59 percentage points year-over-year; for the year ended Dec 31, 2025, it was 9.55%, up 4.55 percentage points from the prior year.

  • EBITDA Margin has now increased for three consecutive years, though with a five-year change of -14.33 percentage points (years ended Dec 2020 to Dec 2025).
  • In earlier years, EBITDA Margin was 5.00% in the year ended Dec 31, 2024 (+19.46 pp), -14.46% in the year ended Dec 31, 2023 (+30.15 pp), -44.61% in the year ended Dec 31, 2022 (-63.36 pp) and 18.74% in the year ended Dec 31, 2021 (-5.13 pp).
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly EBITDA Margin since the quarter ended Dec 31, 2019.
  • Compared with a year earlier, EBITDA Margin has increased for four straight quarters, with an average year-over-year change of +5.43 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBITDA Margin over five years was the quarter ended Sep 30, 2023 (a gain of 90.56 percentage points); the worst was the quarter ended Sep 30, 2022 (a drop of 77.19 percentage points).
  • Per Business Quant data, BWAY's EBITDA Margin in the three quarters before the quarter ended Jun 30, 2026 was 13.98% (quarter ended Mar 31, 2026), 13.96% (quarter ended Dec 31, 2025) and 10.60% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 253.19 Bn 232.22 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 177.78 Bn 148.21 Bn 7.27 Bn 21.86%
3 Danaher 164.28 Bn 148.09 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 155.73 Bn 135.16 Bn 1.96 Bn 41.08%
5 Medtronic 122.75 Bn 88.00 Bn 6.34 Bn 25.55%
6 Stryker 118.23 Bn 104.35 Bn 4.50 Bn 29.67%
7 Boston Scientific 67.03 Bn 61.80 Bn 3.85 Bn 28.17%
8 Becton Dickinson 54.59 Bn 51.74 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 51.62 Bn 35.62 Bn 1.35 Bn 31.93%
10 Brainsway 439.34 Mn 175.73 Mn 12.77 Mn 15.37%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.37%
Mar 31, 2026 13.98%
Dec 31, 2025 13.96%
Sep 30, 2025 10.60%
Jun 30, 2025 6.00%
Mar 31, 2025 6.65%
Dec 31, 2024 6.86%
Sep 30, 2024 4.47%
Jun 30, 2024 6.44%
Mar 31, 2024 1.70%
Dec 31, 2023 2.96%
Sep 30, 2023 -0.58%
Jun 30, 2023 -15.86%
Mar 31, 2023 -53.95%
Dec 31, 2022 -69.98%
Sep 30, 2022 -91.14%
Jun 30, 2022 -23.16%
Mar 31, 2022 -16.81%
Dec 31, 2021 19.16%
Sep 30, 2021 16.65%
API Access

Brainsway EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BWAY&period=max&api_key=YOUR_API_KEY